WallStreetZenWallStreetZen

NASDAQ: CTNM
Contineum Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Contineum Therapeutics earnings were -$49.8M for the trailing 12 months ending Mar 31, 2025, with N/A growth year over year. The latest CTNM earnings report on Mar 31, 2025 announced Q1 2025 earnings of -$16.0M, up 9.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, CTNM reported annual earnings of -$42.3M, with -1,443.2% growth.

CTNM earnings history

Current Revenue
$0.0
Current Earnings
-$49.8M
Current Profit Margin
0%

CTNM Return on Equity

Current Company
-24.6%
Current Industry
-60.2%
Current Market
31.5%
CTNM's Return on Equity (-24.6%)... subscribe to Premium to read more.
High Return on Equity Performance

CTNM undefined

Current Company
-23.5%
Current Industry
-2.5%
CTNM is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when CTNM announces earnings.

CTNM undefined

Current Company
-26.32%
Current Industry
5.8%

CTNM vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
CTNM-$48.70M-$49.83MN/A-$1.98
SGMO-$70.84M-$80.74MN/A-$0.39
THTX$11.53M-$2.59MN/A-$0.06
GNLX-$28.55M-$29.51MN/A-$0.88
ACHV-$44.37M-$46.16MN/A-$1.34
View Top Biotech Stocks

Contineum Therapeutics Earnings Reports & History FAQ

What were Contineum Therapeutics's earnings last quarter?

Contineum Therapeutics (NASDAQ: CTNM) reported Q1 2025 earnings per share (EPS) of -$0.62, up 82.54% year over year. Total CTNM earnings for the quarter were -$15.99 million. In the same quarter last year, Contineum Therapeutics's earnings per share (EPS) was -$3.55.

If you're new to stock investing, here's how to buy Contineum Therapeutics stock.

Is Contineum Therapeutics profitable or losing money?

As of the last Contineum Therapeutics earnings report, Contineum Therapeutics is currently losing money. Contineum Therapeutics's net profit (also called net income) for the twelve months ending Mar 31, 2025 was -$49.83 million, a 398.66% increase year over year.

What was CTNM's earnings growth in the past year?

As of Contineum Therapeutics's earnings date in Q2 2025, Contineum Therapeutics's earnings has grown year over year. CTNM earnings in the past year totalled -$49.83 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.